Back to resources

Resources

Displaying 1 - 8 of 13

CPHI Milan 2026: Investment Is Only Half the Story
CPHI Milan is always a useful barometer for where the pharmaceutical manufacturing indu...

By Charlotte Hirst October 20th, 2026
CPHI Milan 2026: 3 Takeaways as the CDMO Market Bounces Back
The CDMO market has its confidence back. That was the clearest message from CPHI Milan 2026,...

By Austin Hodgson October 15th, 2026
Conferences and Capital The 2026 Workforce Shift
The Restart Nobody AnnouncedProgrammes come back online well before anyone publishes a press...

By Barrington James July 27th, 2026
Biotechnology, Medical Device
Q2 Boardroom Reckoning: What Q1 Made Clear
Amid breakthrough discovery, digital transformation, and shifting regulation, life sciences ...

By Barrington James March 31st, 2026
2025 in Review: Strategic Maturity in Life Sciences
As 2025 draws to a close, it is evident that the industry has not pursued radical transforma...

By Barrington James December 16th, 2025
JP Morgan Healthcare Conference 2025: Key Biopharma Trends, Hiring Challenges & Market Recovery
The 43rd Annual JP Morgan Healthcare Conference was held in San Francisco last month. The mo...

By Barrington James February 6th, 2025
Contract Outsourcing
CDMO/CMO Sector Trends & Challenges
The CDMO/CMO market is experiencing significant growth, particularly in the Drug Substance A...

By Barrington James January 30th, 2025
Contract Outsourcing
Reduced Turnover and Accelerated Growth for a Small Molecule CDMO
The ChallengeA small molecule CDMO faced over a 70% turnover rate, struggled to meet product...

By Barrington James January 28th, 2025